Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Apr 27;19(1):26.
doi: 10.1186/s12868-018-0427-y.

Clinical features and risk factors of neurological involvement in Sjögren's syndrome

Wenjing Ye  1   2 , Siyan Chen  3 , Xinshi Huang  1 , Wei Qin  1 , Ting Zhang  1 , Xiaofang Zhu  1 , Xiaochun Zhu  1 , Chongxiang Lin  4 , Xiaobing Wang  5
Affiliations

Clinical features and risk factors of neurological involvement in Sjögren's syndrome

Wenjing Ye et al. BMC Neurosci. .

Abstract

Background: To investigated distinct manifestations of Sjögren's syndrome (SS) patients with neurological complications and the potential risk factors associated with neurological complications in SS, and to produce a disease evaluation and neurological involvement prediction for SS.

Methods: 566 patients who fulfilled the 2002 classification criteria for SS from the Rheumatology Department of the First Affiliated Hospital of Wenzhou Medical University were included in the cross-sectional study. Clinical, immunological and histological characteristics were surveyed, and potential risk factors for neurological complications were examined by multivariate analysis.

Results: Among 566 SS patients, 184 (32.5%) patients had neurological involvement, with more than 10% got limbs pain, limbs numbness and cerebral infarction, respectively. Of these 184 SS patients with neurological complications, secondary SS (sSS) patients had a higher prevalence of peripheral nervous system (PNS) involvement than primary SS (pSS) patients (31.1 vs. 19%). And sSS patients showed higher total ESSPRI score and higher prevalence of xerostomia and low C3, C4 levels with more liver, articular involvement and saliva gland atrophy, and more severe lymphocyte infiltration in salivary glands than pSS patients. As for the specific factors associated with neurological involvement, low C3 level were found to be significant in pSS or sSS patients who were younger 50 year old, and ANA positivity, cardiac involvement, saliva gland atrophy were demonstrated to be associated in elder pSS patients. And xerophthalmia was found to be associated in sSS patients.

Conclusion: Low complement (C3) levels, xerophthalmia, ANA positive, cardiac involvement and labial salivary gland histological result were good ways to predict neurological complications in different subgroups of SS, which might provide insight into better clinical decision-making, especially at early stages of the disease.

Keywords: Cross-sectional study; Logistic model; Neurological complication; Risk factor; Sjögren’s syndrome.

PubMed Disclaimer

References

    1. Moreira I, Teixeira F, Silva AM, Vasconcelos C, Farinha F, Santos E. Frequent involvement of central nervous system in primary Sjögren syndrome. Rheumatol Int. 2015;35(2):289–294. doi: 10.1007/s00296-014-3097-9. - DOI - PubMed
    1. Vitali C, Bombardieri S, Moutsopoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, Bjerrum KB, Braga S, Coll J, Vita SD. Preliminary criteria for the classification of Sjögren’s syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum. 1993;36(3):340–347. doi: 10.1002/art.1780360309. - DOI - PubMed
    1. Mavragani CP, Moutsopoulos HM. The geoepidemiology of Sjogren’s syndrome. Autoimmun Rev. 2010;9(5):A305–A310. doi: 10.1016/j.autrev.2009.11.004. - DOI - PubMed
    1. Fox RI. Sjogren’s syndrome. Lancet. 2005;366(9482):321–331. doi: 10.1016/S0140-6736(05)66990-5. - DOI - PubMed
    1. Ramos Casals M, Brito Zerón P, Sisó Almirall A, Bosch Aparici FJ. Primary Sjogren syndrome. Br Med J. 2012;344:e3821. doi: 10.1136/bmj.e3821. - DOI - PubMed